RAJEEV RANJAN

About

A learner, pursued Ph.D. form CSIR-CDRI, M.S.(Pharm) in Pharmaceutics from NIPER, Mohali, Bachelor in Pharmacy from Manipal University, Karnataka. After serving reputed pharmaceutical firm for four years, currently holding the position as Assistant Professor in the Faculty of Pharmacy at Gopal Narayan Singh University, Jamuhar, Bihar.

Employment

• Torino Pharmaceuticals Pvt. Ltd., Pithampur Production Chemist
  2022 - 2022
• Gopal Narayan Singh University Assistant Professor
  2019 - Present
• Center of Excellence, Unichem Laboratories Ltd., Goa Senior Research Associate
  2019 - 2022

Education

• National Institute of Pharmaceutical Education and Research M.S. (Pharm)
  2011 - 2013
• Manipal College of Pharmaceutical Sciences B. Pharm
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Injectable Grafts for Hard Tissue Engineering: Current Trends and Future Perspectives
  Drug Development and Industrial Pharmacy 2026 DOI: 10.1080/03639045.2026.2659235
  +Save
• Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies
  Journal of Aerosol Medicine and Pulmonary Drug Delivery 2025 DOI: 10.1089/jamp.2024.0051
  +Save
• Development of Complex Generics and Similar Biological Products: An Industrial Perspective of Reverse Engineering
  AAPS PharmSciTech 2025 DOI: 10.1208/s12249-025-03087-7
  +Save
• A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development
  Current Cancer Therapy Reviews 2024 DOI: 10.2174/0115733947249518231001001728
  +Save
• In silico Molecular Docking and Scrutinizing Druglike Properties of Selected Phytoconstituents Against TAK1, Xanthin Oxidase, and IL-1 β Targets in Gouty Arthritis
  Current Trends in Biotechnology and Pharmacy 2023 DOI: 10.5530/ctbp.2023.4.83
  +Save
• Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against mycobacterium tuberculosis
  Antimicrobial agents and chemotherapy 2019
  +Save
• Preparation and optimization of a dry powder for inhalation of second-line anti-tuberculosis drugs
  International Journal of Pharmaceutics 2018
  +Save
• Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes
  International Journal of Pharmaceutics 2017 DOI: 10.1016/j.ijpharm.2017.03.088
  +Save
• Inhaled drug combinations
  Tuberculosis treatment and prevention 2016
  +Save
• Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain
  Molecular Pharmaceutics 2016
  +Save